Hüseyin Ince

Showing 1-20 of 20 articles

Coronary interventions

A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis

Hamm C, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Berland J, Piot C, Roubille F, Schult I, Allocco D, Nef H

July 17, 2020 | 10.4244/EIJ-D-19-00051

Lessons learned from the MitraSwiss registry

Ince H, D’Ancona G

June 12, 2020 | 10.4244/EIJV16I2A14

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial

Hein R, Gross L, Aradi D, Rieber J, Hadamitzky M, Merkely B, Huczek Z, Ince H, Hummel A, Baylacher M, Massberg S, Trenk D, Sibbing D

August 9, 2019 | 10.4244/EIJ-D-18-01077

MITRA-HR: the French correction vs the MitraClip. The race has started

D’Ancona G, Ince H

July 19, 2019 | 10.4244/EIJV15I4A58

Interventions for stroke

Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study

Bergmann M, Ince H, Kische S, Schmitz T, Meincke F, Schmidt B, Foley DP, Betts TR, Grygier M, Protopopov A, Stein KM, Boersma L

April 20, 2018 | 10.4244/EIJ-D-17-00672

Interventions for valvular disease

Mitral valve: repair/clips/cinching/chordae

Vahanian A, Urena M, Ince H, Nickenig G

September 24, 2017 | 10.4244/EIJ-D-17-00505

Interventions for stroke

Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry

Bergmann M, Betts TR, Sievert H, Schmidt B, Pokushalov E, Kische S, Schmitz T, Meincke F, Stein KM, Boersma L, Ince H

September 20, 2017 | 10.4244/EIJ-D-17-00042

Coronary interventions

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R

July 20, 2017 | 10.4244/EIJ-D-17-00254

Interventions for valvular disease

Combined mitro-aortic pathology: impact of previous aortic valve replacement upon outcomes of MitraClip therapy (from the German transcatheter mitral valve interventions registry)

D’Ancona G, Kische S, Senges J, Ouarrak T, Puls M, Bekeredjian R, Sievert H, Safak E, Ortak J, Oener A, Schillinger W, Ince H

July 20, 2017 | 10.4244/EIJ-D-17-00222

Interventions for valvular disease

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

Naber C, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner M, Latib A, De Marco F, Kische S

December 9, 2016 | 10.4244/EIJ-D-15-00511

Interventions for valvular disease

The MitraClip system: strategies for optimal patient selection and optimised results

Grasso C, Ince H

September 18, 2016 | 10.4244/EIJV12SYA14

Interventions for valvular disease

Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis

Naber C, Pyxaras S, Ince H, Latib A, Frambach P, den Heijer P, Wagner M, Butter C, Colombo A, Kische S

February 12, 2016 | 10.4244/EIJV11I11A254

Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial

Thomas M, Nienaber C, Naber C, Ince H, Erglis A, Vukcevic V, Schäfer U, Ferreira R, Hardt S, Verheye S, Ribeiro V, Sugeng L, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A143

Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve

Kische S, D’Ancona G, Ortak J, Ince H

September 22, 2015 | 10.4244/EIJV11I5A117

Interventions for valvular disease

Treatment of secondary mitral valve regurgitation: why we need combined and evolving percutaneous strategies to tackle this moving target

D’Ancona G, Kische S, Agma H, Ince H

September 17, 2015 | 10.4244/EIJV11SWA13

How should I treat severe paravalvular leakage after TAVI?

Reinthaler M, Empen K, Busch M, Konemann R, Ince H, Felix S

September 27, 2013 | 10.4244/EIJV9I5A104

Mitral valve repair using multiple MitraClips®: a dobutamine stress echocardiography evaluation

Paranskaya L, D’Ancona G, Bozdag-Turan I, Kische S, Akin I, Turan G, Ortak J, Schuetz J, Naber C, Nienaber C, Ince H

April 19, 2013 | 10.4244/EIJV8I12A210

Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata

Paranskaya L, D’Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan G, Divchev D, Rehders T, Schneider H, Ortak J, Naber C, Nienaber C, Ince H

September 28, 2012 | 10.4244/EIJV8I5A88

Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients

Smits P, Nienaber C, Naber C, Colombo A, Ince H, Carlino M, Theuns D, Biagini E, Valgimigli M, Onderwater E, Steendijk P, Peters N, Goedhart D, Serruys P

February 20, 2006

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.